Pacira Pharmaceuticals Inc (PCRX)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Payables turnover		11.76	12.05	8.67	12.30	13.09	13.64	11.47	9.77	13.30	17.30	10.83	13.06	11.25	8.76	11.60	6.89	8.34	6.15	7.16	6.83
Number of days of payables	days	31.03	30.30	42.11	29.68	27.87	26.76	31.83	37.37	27.44	21.10	33.71	27.96	32.45	41.67	31.47	53.01	43.78	59.35	50.99	53.47

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 11.76
= 31.03

To analyze Pacira BioSciences Inc's number of days of payables, we look at the trend over the past eight quarters. The number of days of payables measures how long, on average, the company takes to pay its suppliers or vendors for goods or services purchased on credit.

The number of days of payables has fluctuated over the quarters, ranging from a low of 26.76 days in Q3 2022 to a high of 42.11 days in Q2 2023. Generally, a lower number of days of payables indicates the company is paying its suppliers more quickly, while a higher number suggests a longer payment period.

In Q4 2023, the number of days of payables was 31.03 days, increasing slightly from the previous quarter but remaining within a reasonable range compared to historical data. This could imply that Pacira BioSciences Inc is maintaining stable payment terms with its suppliers.

Overall, the trend in the number of days of payables for Pacira BioSciences Inc shows some variability but generally staying within manageable levels. Monitoring this ratio over time can provide insights into the company's liquidity management and relationships with its suppliers.